Microbiome Changes in Connective Tissue Diseases and Vasculitis: Focus on Metabolism and Inflammation

Int J Mol Sci. 2022 Jun 10;23(12):6532. doi: 10.3390/ijms23126532.

Abstract

The microbial community acts as an active player in maintaining homeostasis and immune functions through a continuous and changeable cross-talk with the host immune system. Emerging evidence suggests that altered microbial composition, known as dysbiosis, might perturb the delicate balance between the microbiota and the immune system, triggering inflammation and potentially contributing to the pathogenesis and development of chronic inflammatory diseases. This review will summarize the current evidence about the microbiome-immunity cross-talk, especially focusing on the microbiota alterations described in patients with rheumatic diseases and on the recent findings concerning the interaction between microbiota, metabolic function, and the immune system.

Keywords: chronic immune-mediated inflammatory diseases; dysbiosis; inflammation; microbiome.

Publication types

  • Review

MeSH terms

  • Connective Tissue Diseases*
  • Dysbiosis
  • Humans
  • Inflammation
  • Microbiota*
  • Vasculitis*

Grants and funding

This research received no external funding.